Fulgent Genetics Inc (FLGT)
Financial leverage ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 1,235,330 | 1,358,400 | 1,354,580 | 1,376,770 | 1,386,050 | 1,405,780 | 1,461,660 | 1,465,590 | 1,278,720 | 1,204,670 | 1,049,860 | 999,083 | 700,461 | 247,311 | 95,915 | 89,325 | 88,756 | 61,145 | 56,436 | 55,652 |
| Total stockholders’ equity | US$ in thousands | 1,136,100 | 1,258,700 | 1,259,760 | 1,264,450 | 1,266,680 | 1,277,050 | 1,304,760 | 1,306,130 | 1,158,750 | 1,036,780 | 912,729 | 801,566 | 569,387 | 186,955 | 87,043 | 81,372 | 82,777 | 54,526 | 51,142 | 49,961 |
| Financial leverage ratio | 1.09 | 1.08 | 1.08 | 1.09 | 1.09 | 1.10 | 1.12 | 1.12 | 1.10 | 1.16 | 1.15 | 1.25 | 1.23 | 1.32 | 1.10 | 1.10 | 1.07 | 1.12 | 1.10 | 1.11 |
December 31, 2023 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,235,330K ÷ $1,136,100K
= 1.09
The financial leverage ratio of Fulgent Genetics Inc has displayed relative stability over the past eight quarters, ranging between 1.08 and 1.12. This ratio indicates that the company's assets are financed primarily through equity rather than debt, as values above 1 suggest a higher proportion of equity in the capital structure. The consistency in the ratio over time indicates a prudent capital structure management strategy, where the company is maintaining a relatively balanced mix of debt and equity financing. However, it is important to monitor any significant changes in this ratio in the future, as shifts towards higher leverage could potentially increase financial risk for the company.
Peer comparison
Dec 31, 2023